{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:53:54Z","timestamp":1781704434427,"version":"3.54.5"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    -rearranged tumors of the gynaecologic tract are rare, but likely under-recognised, neoplasms, which have recently been reported in the ovary and uterus. It is important to identify these neoplasms due to their malignant potential and possible responsiveness to tyrosine kinase inhibition in the metastatic setting. We present the largest series to date of\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    -rearranged tumours of the gynaecologic tract with comprehensive clinicopathologic analysis. Ten cases (7 primary ovarian tumors and 3 primary uterine corpus tumours) with\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    rearrangements were identified in the case files of the contributing authors, and clinical findings, histomorphology, and immunophenotype were reviewed. Patients ranged in age from 26 to 60 years of age. Three of the 10 tumours in our series recurred, including one late recurrence 180 months postoperatively. The 10 cases, in keeping with previous reports in the literature, showed 2 main morphologic patterns: (i) variable admixture of trabecular, nested and tubular\/microfollicular growth, akin to sex cord-stromal morphology; and (ii) cytologically bland, elongated spindle cells with abundant admixed blood vessels and variably myxoid matrix, morphologically suggestive of a low-grade mesenchymal neoplasm such as low-grade endometrial stromal sarcoma. In both scenarios, the immunophenotype was not supportive of the morphologic impression (with the sex cord-like tumours typically showing negative staining for calretinin, inhibin, and WT-1, whereas the tumours resembling low-grade endometrial stromal sarcomas were consistently hormone receptor-negative), and the diagnosis was ultimately made after next-generation sequencing.\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    fusion partners included\n                    <jats:italic toggle=\"yes\">PTCH1<\/jats:italic>\n                    (4 cases),\n                    <jats:italic toggle=\"yes\">ACTB<\/jats:italic>\n                    (4 cases),\n                    <jats:italic toggle=\"yes\">CHD4<\/jats:italic>\n                    (1 case), and\n                    <jats:italic toggle=\"yes\">TXNIP<\/jats:italic>\n                    (1 case). Morpho-molecular correlation suggested that tumours with\n                    <jats:italic toggle=\"yes\">PTCH1::GLI1<\/jats:italic>\n                    fusions were enriched in sex cord-like morphology, whereas tumours with\n                    <jats:italic toggle=\"yes\">ACTB::GLI1<\/jats:italic>\n                    fusions were enriched in low-grade endometrial stromal sarcoma-like morphology. Given that our cases were identified in a relatively short time period, it is likely that\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    -rearranged tumours are more common in the female genital tract than is realised and a high index of suspicion is required to initiate appropriate testing and establish the diagnosis. In the absence of readily available appropriate molecular testing, GLI1 immunohistochemistry can serve as an acceptably accurate surrogate biomarker for\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    rearrangement, since we found that GLI1 immunohistochemistry showed strong, diffuse nuclear staining in 6\n                    <jats:italic toggle=\"yes\">GLI1<\/jats:italic>\n                    -rearranged gynaecologic tumours stained for this study, whereas this was consistently negative, or at most weak\/focal, in an array of 135 morphologic mimics.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002545","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:00:06Z","timestamp":1775196006000},"page":"804-813","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["GLI1-Rearranged Tumors of the Gynecologic Tract"],"prefix":"10.1097","volume":"50","author":[{"given":"Roman E.","family":"Zyla","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Mount Sinai Hospital"},{"name":"Laboratory Medicine and Pathobiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke E.","family":"Howitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalling","family":"Bosse","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freek E.","family":"van Slooten","sequence":"additional","affiliation":[{"name":"Gynaecologic Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Oza","sequence":"additional","affiliation":[{"name":"Medicine, University of Toronto"},{"name":"Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Kolin","sequence":"additional","affiliation":[{"name":"Division of Women\u2019s and Perinatal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Croce","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Bergoni\u00e9"},{"name":"Faculty of Medicine, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Merck","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Bergoni\u00e9"},{"name":"Faculty of Medicine, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Buist","sequence":"additional","affiliation":[{"name":"The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, University College London NHS Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Karnezis","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Alnuaim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjelica","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathobiology"},{"name":"Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Glenn","family":"McCluggage","sequence":"additional","affiliation":[{"name":"Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise A.","family":"Clarke","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathobiology"},{"name":"Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"R1-20260617","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/PAS.0000000000001360","article-title":"Pericytoma with t(7;12) and ACTB-GLI1 fusion: reevaluation of an unusual entity and its relationship to the spectrum of: GLI1 fusion\u2013related neoplasms","volume":"43","author":"Kerr","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R2-20260617","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000001979","article-title":"Distinctive nested glomoid neoplasm: clinicopathologic analysis of 20 cases of a mesenchymal neoplasm with frequent: GLI1 alterations and indolent behavior","volume":"47","author":"Papke","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R3-20260617","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.4730","article-title":"Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma","volume":"239","author":"Spans","year":"2016","journal-title":"J Pathol"},{"key":"R4-20260617","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/modpathol.2017.68","article-title":"Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene","volume":"30","author":"Graham","year":"2017","journal-title":"Mod Pathol"},{"key":"R5-20260617","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/PAS.0000000000002272","article-title":"A comprehensive clinicopathologic and molecular reappraisal of GLI1-altered mesenchymal tumors with pooled outcome analysis showing poor survival in GLI1- amplified versus GLI1-rearranged tumors","volume":"48","author":"Saoud","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000001439","article-title":"Head and neck mesenchymal neoplasms with GLI1 gene alterations: a pathologic entity with distinct histologic features and potential for distant metastasis","volume":"44","author":"Xu","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00428-021-03224-0","article-title":"GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity","volume":"480","author":"Liu","year":"2022","journal-title":"Virchows Arch"},{"key":"R8-20260617","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PGP.0000000000001110","article-title":"PTCH1::GLI1 fusion tumors of the ovary: a clinicopathologic study of 3 cases","volume":"44","author":"Bakkar","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20260617","doi-asserted-by":"crossref","first-page":"100848","DOI":"10.1016\/j.modpat.2025.100848","article-title":"GLI1-altered tumors of the ovary: a report of four cases of an underrecognized neoplasm that may mimic sex cord-stromal tumors","volume":"38","author":"Devins","year":"2025","journal-title":"Mod Pathol"},{"key":"R10-20260617","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PGP.0000000000000542","article-title":"Pericytoma with t(7;12): the first ovarian case reported and a review of the literature","volume":"38","author":"Koh","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/his.14785","article-title":"GLI1-rearranged mesenchymal tumor in the ovary","volume":"81","author":"Hui","year":"2022","journal-title":"Histopathol"},{"key":"R12-20260617","doi-asserted-by":"crossref","first-page":"998","DOI":"10.6004\/jnccn.2021.7058","article-title":"PTCH1-GLI1 fusion\u2013positive ovarian tumor: report of a unique case with response to tyrosine kinase inhibitor pazopanib","volume":"19","author":"Alwaqfi","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R13-20260617","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.3390\/cancers12092604","article-title":"Molecular classification of endometrial stromal sarcomas using RNA sequencing defines nosological and prognostic subgroups with different natural history","volume":"12","author":"Brahmi","year":"2020","journal-title":"Cancers"},{"key":"R14-20260617","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/gcc.23099","article-title":"Expanding the spectrum of GLI1-altered mesenchymal tumors\u2014a high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract","volume":"62","author":"Punjabi","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"key":"R15-20260617","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.106003","article-title":"Ovarian GLI1 fusion tumors mimicking sex cord-stromal tumors: clinicopathological and molecular characterization of a five-case series","volume":"167","author":"Yang","year":"2026","journal-title":"Hum Pathol"},{"key":"R16-20260617","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAS.0000000000002018","article-title":"GLI1 immunohistochemistry distinguishes mesenchymal neoplasms with GLI1 alterations from morphologic mimics","volume":"47","author":"Parrack","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R17-20260617","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00428-023-03687-3","article-title":"The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms","volume":"484","author":"Machado","year":"2024","journal-title":"Virchows Arch"},{"key":"R18-20260617","doi-asserted-by":"crossref","first-page":"100635","DOI":"10.1016\/j.modpat.2024.100635","article-title":"GLI1-altered mesenchymal tumor\u2014multiomic characterization of a case series and patient-level meta-analysis of one hundred sixty-seven cases for risk stratification","volume":"38","author":"Yeung","year":"2025","journal-title":"Mod Pathol"},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0002-9440(10)63723-6","article-title":"Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12)","volume":"164","author":"Dahl\u00e9n","year":"2004","journal-title":"Am J Pathol"},{"key":"R20-20260617","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.humpath.2012.01.019","article-title":"Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone","volume":"43","author":"Bridge","year":"2012","journal-title":"Hum Pathol"},{"key":"R21-20260617","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.modpat.2023.100386","article-title":"GLI1-altered mesenchymal tumors with ACTB or PTCH1 fusion: a molecular and clinicopathologic analysis","volume":"37","author":"Kerr","year":"2024","journal-title":"Mod Pathol"},{"key":"R22-20260617","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/jclinpath-2020-206431","article-title":"Gene of the month: GLI-1","volume":"73","author":"Chetty","year":"2020","journal-title":"J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002545","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:05Z","timestamp":1781701385000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002545"}},"subtitle":["A Detailed Clinicopathologic Study of 10 Cases"],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002545","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"2025-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}